Its inhibition seems interesting in acute leukemias since PRMT1 increases the transcriptional activity and self-renewal of cells with KMT2A (MLL) or RUNX1-RUNX1T1 (AML1-ETO) rearrangements [141]. Here, RUNX1 is linked to acute leukemia.